Cite
Shedlock DJ, Tingey C, Mahadevan L, et al. Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity. Vaccines (Basel). 2014;2(2):196-215doi: 10.3390/vaccines2020196.
Shedlock, D. J., Tingey, C., Mahadevan, L., Hutnick, N., Reuschel, E. L., Kudchodkar, S., Flingai, S., Yan, J., Kim, J. J., Ugen, K. E., Weiner, D. B., & Muthumani, K. (2014). Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity. Vaccines, 2(2), 196-215. https://doi.org/10.3390/vaccines2020196
Shedlock, Devon J, et al. "Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity." Vaccines vol. 2,2 (2014): 196-215. doi: https://doi.org/10.3390/vaccines2020196
Shedlock DJ, Tingey C, Mahadevan L, Hutnick N, Reuschel EL, Kudchodkar S, Flingai S, Yan J, Kim JJ, Ugen KE, Weiner DB, Muthumani K. Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity. Vaccines (Basel). 2014 Mar 25;2(2):196-215. doi: 10.3390/vaccines2020196. PMID: 26344618; PMCID: PMC4494262.
Copy
Download .nbib